Direxion Daily Healthcare Bull 3X Shares (CURE)

Add to Watchlists
Create an Alert
22.51 +0.11  +0.49% NYSE Arca Feb 9, 12:59 Delayed 2m USD
View Full Chart
CURE Price Chart

CURE Key Stats

Expense Ratio (10-31-15) 0.95%
Assets Under Management (2-8-16) 206.33M
30-Day Average Volume (2-8-16) 284948.2
Net Asset Value (2-8-16) 22.43
Discount or Premium to NAV (2-8-16) -0.13%
Turnover Ratio (10-31-15) 32.00%

CURE Asset Allocation

Type % Net % Long % Short
Cash -190.3% 111.0% 301.3%
Stock 290.3% 290.3% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Jan. 31, 2016

CURE Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Jan. 31, 2016
Region breakdown data is calculated by using the long position holdings of the portfolio.

CURE Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 0.00%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Jan. 31, 2016

CURE Stock Market Capitalization

Giant --
Large --
Medium --
Small --
Micro --
As of Jan. 31, 2016
View More Holdings

CURE Top 7 Holdings

Symbol Name % Weight Price % Chg
-- Health Care Select Sector 167.9% -- --
-- Health Care Select Sector 57.23% -- --
-- Health Care Select Sector 21.87% -- --
-- Health Care Select Sector 16.61% -- --
XLV Health Care Select Sector SPDR 14.14% 63.51 -0.02%
-- Health Care Select Sector 12.47% -- --
XLV Health Care Select Sector SPDR® ETF 0.11% 63.51 -0.02%
As of Jan. 31, 2016
Advertisement

CURE Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Alternative
Broad Category Alternative
Category Name Trading-Leveraged Equity
Prospectus Objective Specialty - Health
Fund Owner Firm Name Direxion Funds
Benchmark Index
S&P Health Care Select Sector TR USD
300.0%

CURE Manager Info

Name Tenure
Paul Brigandi 4.55 yrs

CURE Risk Info

Beta 2.501
Max Drawdown (All) 44.44%
Historical Sharpe (10y) --
Historical Sortino (All) 2.037
30-Day Rolling Volatility 61.93%
Daily Value at Risk (VaR) 1% (All) 8.09%
Monthly Value at Risk (VaR) 1% (All) 29.75%

CURE Fundamentals

Dividend Yield TTM (2-9-16) 0%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio --
Weighted Average Price to Book Ratio --
Weighted Median ROE --
Weighted Median ROA --
Forecasted Dividend Yield 1.56%
Forecasted PE Ratio 18.89
Forecasted Price to Sales Ratio 1.878
Forecasted Price to Book Ratio 3.428
Number of Holdings 16
As of Jan. 31, 2016

CURE Growth Estimates

Forecasted 5 Yr Earnings Growth 9.56%
Forecasted Book Value Growth 10.22%
Forecasted Cash Flow Growth 10.85%
Forecasted Earnings Growth 11.62%
Forecasted Revenue Growth 8.79%
As of Jan. 31, 2016

CURE Performance

  Returns Total Returns
1M -19.94% -19.94%
3M -32.41% -32.41%
6M -44.24% -44.24%
1Y -31.37% -31.37%
3Y 164.5% 179.0%
5Y -- --
As of Feb. 8, 2016

CURE Net Flows

1M -11.72M
3M -36.37M
6M -39.93M
YTD -11.72M
1Y 19.46M
3Y 198.21M
5Y --
As of Jan. 31, 2016

CURE Comparables

Edit

CURE Attributes

Key Dates
Inception Date 6/15/2011
Last Annual Report Date 10/31/2015
Last Prospectus Date 2/27/2015
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund Yes
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

CURE Excel Add-In Codes

  • Name: =YCI("CURE","name")
  • Broad Asset Class: =YCI("CURE", "broad_asset_class")
  • Broad Category: =YCI("CURE", "broad_category_group")
  • Prospectus Objective: =YCI("CURE", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.